Post-Inflammatory Hyperpigmentation — Prevention and Treatment

Last updated: 5 March 2026

Post-Inflammatory Hyperpigmentation: Prevention and Treatment

Post-inflammatory hyperpigmentation (PIH) is one of the most common dermatological concerns worldwide, affecting individuals of all skin types but disproportionately impacting those with darker complexions. Following any form of skin inflammation or injury — from acne and eczema to aesthetic procedures — PIH can leave persistent dark marks that may take months or even years to fade without intervention. Understanding the pathophysiology and treatment options is essential for both prevention and effective management.

What Is Post-Inflammatory Hyperpigmentation?

PIH occurs when inflammation triggers an overproduction of melanin by melanocytes or the transfer of melanin to surrounding keratinocytes. This excess pigment is deposited in the epidermis (superficial PIH) or dermis (deep PIH), creating flat, darkened patches at the site of the original inflammation.

According to a comprehensive review in the Journal of Clinical and Aesthetic Dermatology, PIH is distinct from true scarring — it does not involve structural changes to the skin architecture. However, it can be equally distressing for patients and may significantly impact quality of life.

Epidermal vs. Dermal PIH

• Epidermal PIH — appears tan to dark brown, responds well to topical treatments, and typically resolves within 6-12 months
• Dermal PIH — appears grey-blue or grey-brown, is more resistant to treatment, and may persist for years. Wood’s lamp examination can help distinguish between the two types

Common Causes of PIH

Any inflammatory process can trigger PIH, but the most common causes include acne vulgaris (the most frequent trigger), eczema and dermatitis, psoriasis flares, insect bites, burns (including sunburn), allergic reactions, aesthetic procedures (laser, peels, microneedling), and folliculitis.

Risk Factors

PIH susceptibility varies significantly among individuals. Key risk factors include Fitzpatrick skin types III-VI (higher melanin content), genetic predisposition, hormonal influences (pregnancy, oral contraceptives), UV exposure during the inflammatory phase, and inappropriate treatment of the initial inflammatory condition.

Prevention Strategies

Prevention is significantly more effective than treatment for PIH. Our clinical team at Axiom Aesthetics emphasises the following preventative measures.

Sun Protection

UV exposure is the single most important modifiable risk factor for PIH development and persistence. Broad-spectrum SPF 50 should be applied daily, reapplied every two hours during exposure, and supplemented with physical protection (hats, shade). Research in Pigment Cell and Melanoma Research demonstrates that even visible light can exacerbate PIH in darker skin types, making iron oxide-containing sunscreens particularly beneficial.

Early Treatment of Inflammation

Prompt, appropriate treatment of acne, eczema, and other inflammatory conditions minimises the duration of inflammation and consequently reduces PIH risk.

Procedure-Related Prevention

When aesthetic procedures carry PIH risk, our practitioners may prescribe pre-treatment with tyrosinase inhibitors (such as hydroquinone or arbutin) for 2-4 weeks before the procedure, conservative treatment parameters in higher-risk skin types, post-procedure anti-inflammatory protocols, and strict sun avoidance during recovery.

Evidence-Based Treatment Options

Topical Treatments

Hydroquinone (2-4%): Remains the gold standard topical depigmenting agent. It inhibits tyrosinase, the enzyme responsible for melanin production. UK prescribing guidelines recommend limiting use to 3-6 month courses to avoid ochronosis (a paradoxical darkening with prolonged use).

Azelaic acid (15-20%): A well-tolerated alternative that inhibits tyrosinase and has anti-inflammatory properties. Safe for use in pregnancy, making it a valuable option for hormonal PIH.

Vitamin C (L-ascorbic acid): An antioxidant that inhibits melanogenesis and provides photoprotection. Concentrations of 10-20% have demonstrated efficacy in clinical trials published in the Indian Dermatology Online Journal.

Retinoids: Tretinoin and adapalene accelerate epidermal turnover, promoting faster elimination of melanin-laden keratinocytes. They also inhibit melanin transfer between melanocytes and keratinocytes.

Niacinamide (4-5%): Inhibits melanosome transfer and has been shown to reduce hyperpigmentation by up to 35% over 8 weeks in randomised controlled trials.

Chemical Peels

Superficial peels using glycolic acid (20-50%), salicylic acid (20-30%), or mandelic acid (30-40%) can accelerate PIH resolution by promoting epidermal turnover. Mandelic acid is particularly suitable for darker skin types due to its larger molecular size and slower penetration, reducing irritation risk.

Laser and Light Treatments

Q-switched lasers (Nd:YAG 1064nm) can target dermal melanin without damaging the epidermis, making them suitable for deep PIH. Intense pulsed light (IPL) and fractional non-ablative lasers may also be effective but carry higher PIH risk in darker skin types and must be used with caution.

Microneedling

When combined with depigmenting agents (tranexamic acid, vitamin C), microneedling can enhance penetration and efficacy of topical treatments while stimulating collagen production.

Treatment Considerations for Darker Skin Types

Treating PIH in Fitzpatrick skin types IV-VI requires particular expertise. Aggressive treatments that cause inflammation can paradoxically worsen PIH. Our approach prioritises gentle, consistent treatment over aggressive intervention, conservative energy device settings, adequate pre-treatment preparation, extended post-treatment pigment-prevention protocols, and regular monitoring for treatment-induced PIH.

Frequently Asked Questions

How long does PIH take to fade on its own?

Without treatment, epidermal PIH typically fades within 3-12 months, while dermal PIH may persist for years. Treatment can significantly accelerate this timeline.

Can PIH become permanent?

While PIH is generally self-limiting, deep dermal PIH can persist for many years and may appear permanent without treatment. Consistent use of depigmenting agents and sun protection can gradually improve even longstanding PIH.

Is PIH the same as melasma?

No. While both conditions involve hyperpigmentation, melasma is a chronic condition driven primarily by hormonal and UV factors, whereas PIH is triggered by a specific inflammatory event. The two conditions require different treatment approaches.

Can I prevent PIH after aesthetic treatments?

Risk can be significantly reduced through pre-treatment preparation, conservative treatment parameters, strict sun avoidance, and post-treatment use of depigmenting agents. Discuss your PIH risk with your practitioner before any procedure.

This article is for informational purposes only and does not constitute medical advice. PIH treatment should be supervised by a qualified dermatologist or aesthetic practitioner, particularly for darker skin types. All treatments at Axiom Aesthetics are tailored to individual skin type and condition.